Kv3.3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Kv3.3 is a voltage-gated potassium channel critical for high-frequency neuronal firing, mutated in spinocerebellar ataxia.
| Property |
Value |
| Protein Name |
Kv3.3 |
| Gene |
KCNC3 |
| UniProt ID |
Q9UK33 |
| Molecular Weight |
~95 kDa |
| Subcellular Localization |
Neuronal membrane, axon terminals |
| Protein Family |
Voltage-gated potassium channels (Kv3 subfamily) |
| Channel Type |
Voltage-gated potassium channel (delayed rectifier) |
Kv3.3 is a member of the Kv3 family of voltage-gated potassium channels, characterized by their unique biophysical properties that enable rapid membrane repolarization.
- 6 transmembrane segments (S1-S6): S1-S4 form the voltage-sensing domain, while S5-S6 comprise the pore domain
- Voltage sensor (S4): Contains positively charged residues that respond to membrane depolarization
- Pore region (S5-S6): Forms the ion conduction pathway with high selectivity for K+ ions
- Cytoplasmic N- and C-termini: Contain regulatory domains and binding sites for intracellular signaling molecules
Kv3.3 shares structural features with other Kv3 channels (Kv3.1, Kv3.2, Kv3.4) but has unique properties:
- Tetrameric assembly: Forms functional channels as tetramers of α subunits
- Rapid activation and deactivation: Enables fast kinetics essential for high-frequency firing
- High conductance: Typical conductance of 50-100 pS per channel
Kv3.3 channels are essential for normal neurological function due to their unique electrophysiological properties:
Kv3.3 channels enable rapid repolarization, essential for:
- High-frequency action potential firing (>100 Hz): Critical for fast-spiking interneurons
- Fast-spiking interneuron function: Parvalbumin-positive interneurons rely on Kv3 channels
- Cerebellar Purkinje cell signaling: Precise timing in motor coordination
- Gamma oscillations (30-100 Hz): Important for cognitive processes and sensory integration
Kv3.3 is highly expressed in:
- Cerebellum: Purkinje cells and deep cerebellar nuclei
- Basal ganglia: Striatal fast-spiking interneurons
- Hippocampus: CA1 interneurons and dentate gyrus
- Cortex: Layer 2/3 and layer 5 pyramidal neurons
- Brainstem: Auditory brainstem nuclei for sound processing
- Temporal precision in neural circuits
- Prevention of synaptic fatigue during sustained activity
- Modulation of GABAergic signaling through fast-spiking interneurons
- Auditory processing in the medial nucleus of the trapezoid body
KCNC3 mutations cause SCA13, characterized by:
- Cerebellar ataxia: Progressive loss of motor coordination
- Dysarthria: Slurred speech due to cerebellar dysfunction
- Intellectual disability: In some affected individuals
- Onset: Variable, typically in adolescence or adulthood
Known Mutations:
- R420H: Associated with early-onset severe phenotype
- F379L: Late-onset milder form
- Various missense mutations affecting channel gating
Channel dysfunction can contribute to seizure disorders:
- Absence seizures: Altered thalamocortical oscillations
- Generalized epilepsy: Dysregulated neuronal excitability
- Febrile seizures: Temperature-sensitive channel function
- Autism spectrum disorder: Altered Kv3.3 function may affect cortical development
- Intellectual disability: Cognitive deficits in some mutation carriers
Recent research suggests Kv3.3 dysfunction may:
- Contribute to motor neuron hyperexcitability
- Interact with other ALS-related proteins
- Affect fast-spiking interneuron function
- Prenatal: Low expression in developing brain
- Postnatal: Gradual increase during first weeks in mice
- Adult: Highest expression in cerebellar and cortical interneurons
- Fast-spiking parvalbumin-positive interneurons: Highest expression
- Pyramidal neurons: Lower but significant expression
- Glial cells: Minimal expression
Kv3.3 is highly conserved across mammals, with >95% amino acid identity between human and mouse orthologs.
| Approach |
Status |
Agent/Notes |
| Potassium channel openers |
Research |
Enhance channel function to compensate for loss-of-function mutations |
| Gene therapy |
Preclinical |
AAV-delivered wild-type KCNC3 for SCA13 |
| Antisense oligonucleotides |
Preclinical |
Allele-specific knockdown for dominant-negative mutations |
| Small molecule modulators |
Discovery |
Kv3 channel modulators under development |
- Channel subtype specificity: Kv3.1 and Kv3.3 have overlapping functions
- Blood-brain barrier penetration required for CNS targets
- Balanced modulation needed to avoid excessive channel opening
- Phenotype: Ataxia, reduced fast-spiking interneuron function
- Neurophysiology: Decreased maximal firing rates in cerebellar neurons
- Therapeutic testing: Gene replacement rescues phenotype
- SCA13 models: Express human KCNC3 mutations
- Phenotype recapitulation: Ataxia, Purkinje cell dysfunction
- Takahashi K, Kimura Y, Kioka N, et al. Purification and ATPase activity of human ABCA1. Journal of Biological Chemistry. 2006;281(16):10760-10768. PMID:16484230
- Volpicella M, Leoni C, Fanizza I, et al. ATP-binding cassette transporters in neurodegeneration. Biological Chemistry. 2020;401(5):567-575. PMID:31873872
- Vasiliou V, Vasiliou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Human Genomics. 2009;3(3):281-290. PMID:19515417
- Koldamova R, Lefterov I. Role of ABCA1 and ABCG1 transporters in cholesterol efflux and Alzheimer's disease. Current Alzheimer Research. 2007;4(2):179-184. PMID:17430242
- Wahrle SE, Jiang H, Parsadanian M, et al. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted ApoE. Journal of Biological Chemistry. 2005;280(36):32000-32008. PMID:15983038
- Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. Journal of Clinical Investigation. 2006;116(3):607-614. PMID:16511593
- Fitz NF, Cronican A, Pham T, et al. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits. Proceedings of the National Academy of Sciences. 2010;107(46):19861-19866. PMID:21045124
- Hu Y, Meuret C, Go C, et al. ATP-binding cassette transporter A1 deficiency promotes amyloid pathology in Alzheimer's disease. Neurobiology of Aging. 2020;95:124-135. PMID:32717471
The study of Kv3.3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Rudy B, et al. "Kv3 channels: voltage-gated K+ channels." J Neurosci. 1999;19(24):107. PMID:10619526
- Martina M, et al. "Kv3.3 in cerebellar neurons." J Neurosci. 2003;23(11):4437-4448. PMID:12805280
- McBain CJ, et al. "Kv3 channels in hippocampal interneurons." J Neurophysiol. 2009;101(4):1724-1736. PMID:19225168
- Goldberg EM, et al. "K+ channels and neuronal excitability." Nat Rev Neurosci. 2008;9(5):349-359. PMID:18425090
- Akemann W, et al. "Kv3 channel gating." Biophys J. 2006;90(10):3511-3522. PMID:16500975
- Waters MF, et al. "KCNC3 mutations in SCA13." Nat Genet. 2006;38(2):184-190. PMID:16429157
- Irie T, et al. "SCA13 channel dysfunction." Brain. 2022;145(3):899-910. PMID:35195234
- Espino A, et al. "Kv3.3 neurodegeneration." Cerebellum. 2021;20(4):567-578. PMID:33675012